NOVT trades 21.7% below Wall Street's consensus target of $180.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes NOVT achieves its forward estimates and maintains a stable P/E multiple of 41.2x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Novanta Inc. (NOVT) has a Wall Street consensus price target of $180.00, based on estimates from 3 covering analysts. With the stock currently trading at $147.85, this represents a potential upside of +21.7%. The company has a market capitalization of $5.27B.
Analyst price targets range from a low of $180.00 to a high of $180.00, representing a 0% spread in expectations. The median target of $180.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, NOVT trades at a trailing P/E of 100.6x and forward P/E of 41.2x. The forward PEG ratio of 12.50 reflects a premium valuation. Analysts expect EPS to grow +175.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $94.32, with bear and bull scenarios of $59.42 and $124.27 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MKSIMKS Inc. | $23.5B | $349.57 | $380.22 | +8.8% | Buy | 29.9x | 29 |
CGNXCognex Corporation | $10.7B | $64.20 | $71.75 | +11.8% | Buy | 43.1x | 31 |
COHRCoherent, Inc. | $49.8B | $314.13 | $333.14 | +6.1% | Buy | 57.6x | 30 |
KLICKulicke and Soffa Industries, Inc. | $5.5B | $105.87 | $70.00 | -33.9% | Buy | 31.0x | 11 |
IPGPIPG Photonics Corporation | $4.1B | $96.60 | $151.50 | +56.8% | Buy | 76.0x | 27 |
AEISAdvanced Energy Industries, Inc. | $10.9B | $287.73 | $424.29 | +47.5% | Buy | 30.8x | 25 |
LSCCLattice Semiconductor Corporation | $17.9B | $130.60 | $141.11 | +8.0% | Buy | 124.3x | 17 |
VIAVViavi Solutions Inc. | $9.3B | $40.22 | $39.00 | -3.0% | Buy | 42.9x | 19 |
ISRGIntuitive Surgical, Inc. | $151.3B | $427.30 | $597.78 | +39.9% | Buy | 40.9x | 55 |
SYKStryker Corporation | $120.1B | $313.38 | $387.46 | +23.6% | Buy | 20.9x | 51 |
Quick answers to the most common questions about buying NOVT stock.
The consensus Wall Street price target for NOVT is $180, representing 21.7% upside from the current price of $147.85. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
NOVT has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $180 implies 21.7% upside from current levels.
At a forward P/E of 41.1838x, NOVT trades at a premium valuation. The consensus price target of $180 (21.7% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $180 for NOVT, while the most conservative target is $180. The consensus of $180 represents the median expectation. Our quantitative valuation model projects a bull case target of $124 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NOVT is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NOVT stock forecast based on 3 Wall Street analysts shows a consensus price target of $180, with estimates ranging from $180 (bear case) to $180 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $94, with bear/bull scenarios of $59/$124.
Our quantitative valuation model calculates NOVT's fair value at $94 (base case), with a bear case of $59 and bull case of $124. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
NOVT trades at a forward P/E ratio of 41.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 100.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on NOVT, with a "Buy" consensus rating and $180 price target (21.7% upside). 2 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NOVT analyst price targets range from $180 to $180, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $180 consensus represents the middle ground. Our model's $59-$124 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.